Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
59.92
+0.37 (0.62%)
At close: Jun 6, 2025, 4:00 PM
59.47
-0.45 (-0.75%)
After-hours: Jun 6, 2025, 7:07 PM EDT
Globus Medical Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Globus Medical stock ranges from a low of $68 to a high of $115. The average analyst price target of $94.3 forecasts a 57.38% increase in the stock price over the next year.
Price Target: $94.30 (+57.38%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 5 | 4 | 4 | 4 | 3 |
Buy | 5 | 5 | 5 | 5 | 5 | 5 |
Hold | 2 | 3 | 4 | 4 | 4 | 5 |
Sell | 1 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 27, 2025 |
BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 27, 2025 |
Truist Securities | Truist Securities | Hold Maintains $80 → $68 | Hold | Maintains | $80 → $68 | +13.48% | May 12, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $100 → $80 | Buy | Maintains | $100 → $80 | +33.51% | May 9, 2025 |
Truist Securities | Truist Securities | Hold Maintains $82 → $80 | Hold | Maintains | $82 → $80 | +33.51% | Apr 11, 2025 |
Financial Forecast
Revenue This Year
2.91B
from 2.52B
Increased by 15.43%
Revenue Next Year
3.17B
from 2.91B
Increased by 9.01%
EPS This Year
3.33
from 0.75
Increased by 344.52%
EPS Next Year
3.79
from 3.33
Increased by 13.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.0B | 3.4B | 3.6B | ||
Avg | 2.9B | 3.2B | 3.4B | ||
Low | 2.7B | 2.9B | 3.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 20.8% | 16.6% | 14.2% | ||
Avg | 15.4% | 9.0% | 6.8% | ||
Low | 8.6% | 1.0% | -1.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.67 | 4.23 | 4.70 | ||
Avg | 3.33 | 3.79 | 4.27 | ||
Low | 2.97 | 3.24 | 3.68 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 389.7% | 26.9% | 24.2% | ||
Avg | 344.5% | 13.6% | 12.6% | ||
Low | 295.9% | -2.7% | -3.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.